Fischli Fund supports research on fructose metabolism

With another donation, the Walter & Edith Fischli Fund supports the work of Prof. Wilhelm Krek's research group on the connection between fructose metabolism and cancer development.


Already in 2015 Dr. Walter Fischli, co-founder of the biopharmaceutical company Actelion, supported the work of the research group of Prof. Wilhelm Krek after its breakthrough in the field of fructose metabolism with a generous donation. More information about the current state of research in this field can be found in an external page article by the ETH Foundation.

Link to the Krek website.

JavaScript has been disabled in your browser